Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin

Martin Metz(Humboldt-Universität zu Berlin), Marcus Maurer(Humboldt-Universität zu Berlin)

Theranostics

January 1, 2017

10.7150/thno.18304

Cited by 135

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

|Allergy|2018|1.4k

The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

|Allergy|2014|1.2k

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

|Allergy|2021|1.2k

The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

|Dermatology Review|2015|428

Epidemiology of urticaria: a representative cross-sectional population survey

|Clinical and Experimental Dermatology|2010|363